Adverse Effects of Systemic Immunosuppression in Keratolimbal Allograft

Table 1

Oral immunosuppression therapy regimen.

Class	Starting dose	Medication	Number of patients	Avg. duration (months)
Corticosteroid	1 mg/kg/day	Prednisone	16	12.8 (Median:10, Range: 3–25)
Calcineurin inhibitor	3-4 mg/kg/day	Cyclosporine	4	13.7 (Range: 4–19)
	2–4 mg BID	Tacrolimus	10	17.8 (Range: 5–25)
Antimetabolite	100–150 mg/day	Azathioprine	2	5.7 (Range: 1–16)
	500–1000 mg BID	Mycophenolate mofetil	12	16.9 (Range: 5–39)
IL-2 inhibitor	2 mg/day	Sirolimus	1	22